galunisertib
Showing 1 - 8 of 8
Carcinosarcoma, Ovarian Trial in Oklahoma City (Galunisertib, Paclitaxel, Carboplatin)
Active, not recruiting
- Carcinosarcoma, Ovarian
- Galunisertib
- +2 more
-
Oklahoma City, OklahomaStephenson Cancer Center, University of Oklahoma Health Sciences
Sep 27, 2021
Nasopharyngeal Carcinoma Trial in Guangzhou (GP+DDP, Palbociclib, Intensity-modulated radiotherapy)
Not yet recruiting
- Nasopharyngeal Carcinoma
- GP+DDP
- +4 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 2, 2021
Colorectal Cancer Metastatic Trial in Amsterdam (Galunisertib)
Withdrawn
- Colorectal Cancer Metastatic
- Galunisertib
-
Amsterdam, Noord-Holland, NetherlandsAntoni van Leeuwenhoek (NKI-AVL)
Jul 22, 2019
Metastatic Pancreatic Cancer Trial in Worldwide (Galunisertib, Durvalumab)
Completed
- Metastatic Pancreatic Cancer
- Galunisertib
- Durvalumab
-
Scottsdale, Arizona
- +10 more
Aug 2, 2019
MDS Trial in Germany, Italy, Spain (Galunisertib, Placebo)
Completed
- Myelodysplastic Syndromes
- Galunisertib
- Placebo
-
Dresden, Germany
- +13 more
Aug 28, 2019
Tumor Trial in New York City (Galunisertib)
Completed
- Neoplasm
- Galunisertib
-
New York City, New YorkMemorial Sloan Kettering Cancer Center
Oct 4, 2016
Healthy Trial in Leeds (Galunisertib)
Completed
- Healthy
- Galunisertib
-
Leeds, West Yorkshire, United KingdomFor additional information regarding investigative sites for thi
Jun 30, 2016